McIlrath & Eck’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $84.9K | Buy |
980
+519
| +113% | +$49.7K | 0.01% | 409 |
|
|
2025
Q4 | $44.3K | Buy |
461
+56
| +14% | +$5.44K | ﹤0.01% | 369 |
|
|
2025
Q3 | $38.6K | Sell |
405
-77
| -16% | -$7.08K | ﹤0.01% | 376 |
|
|
2025
Q2 | $42K | Buy |
482
+1
| +0.2% | +$85 | ﹤0.01% | 352 |
|
|
2025
Q1 | $43.2K | Buy |
481
+71
| +17% | +$6.35K | 0.01% | 346 |
|
|
2024
Q4 | $32.7K | Buy |
410
+172
| +72% | +$14.9K | ﹤0.01% | 394 |
|
|
2024
Q3 | $21.4K | Sell |
238
-96
| -29% | -$8.08K | ﹤0.01% | 460 |
|
|
2024
Q2 | $26.3K | Hold |
334
| – | – | ﹤0.01% | 401 |
|
|
2024
Q1 | $29.1K | Buy |
334
+83
| +33% | +$7.08K | ﹤0.01% | 376 |
|
|
2023
Q4 | $20.7K | Buy |
251
+68
| +37% | +$5.18K | ﹤0.01% | 404 |
|
|
2023
Q3 | $14.3K | Hold |
183
| – | – | ﹤0.01% | 467 |
|
|
2023
Q2 | $16.1K | Sell |
183
-117
| -39% | -$10.1K | ﹤0.01% | 456 |
|
|
2023
Q1 | $24.2K | Hold |
300
| – | – | 0.01% | 378 |
|
|
2022
Q4 | $23.3K | Sell |
300
-100
| -25% | -$8.11K | 0.01% | 385 |
|
|
2022
Q3 | $32K | Buy |
400
+90
| +29% | +$8.09K | 0.01% | 327 |
|
|
2022
Q2 | $28K | Hold |
310
| – | – | 0.01% | 330 |
|
|
2022
Q1 | $34K | Buy |
310
+82
| +36% | +$8.66K | 0.01% | 309 |
|
|
2021
Q4 | $24K | Sell |
228
-59
| -21% | -$6.83K | 0.01% | 377 |
|
|
2021
Q3 | $36K | Sell |
287
-47
| -14% | -$6.08K | 0.01% | 287 |
|
|
2021
Q2 | $41K | Sell |
334
-523
| -61% | -$65.7K | 0.01% | 258 |
|
|
2021
Q1 | $101K | Sell |
857
-350
| -29% | -$41K | 0.04% | 124 |
|
|
2020
Q4 | $141K | Hold |
1,207
| – | – | 0.05% | 77 |
|
|
2020
Q3 | $125K | Sell |
1,207
-47
| -4% | -$4.72K | 0.05% | 70 |
|
|
2020
Q2 | $115K | Buy |
1,254
+293
| +30% | +$28.1K | 0.05% | 69 |
|
|
2020
Q1 | $87K | Buy |
961
+127
| +15% | +$13.5K | 0.05% | 74 |
|
|
2019
Q4 | $95K | Sell |
834
-47
| -5% | -$5.16K | 0.05% | 85 |
|
|
2019
Q3 | $96K | Sell |
881
-21
| -2% | -$2.19K | 0.05% | 73 |
|
|
2019
Q2 | $82K | Hold |
902
| – | – | 0.05% | 89 |
|
|
2019
Q1 | $82K | Buy |
902
+158
| +21% | +$14.1K | 0.05% | 89 |
|
|
2018
Q4 | $68K | Buy |
744
+9
| +1% | +$841 | 0.04% | 98 |
|
|
2018
Q3 | $72K | Buy |
735
+20
| +3% | +$1.85K | 0.04% | 106 |
|
|
2018
Q2 | $61K | Buy |
715
+29
| +4% | +$2.42K | 0.04% | 104 |
|
|
2018
Q1 | $55K | Sell |
686
-52
| -7% | -$4.29K | 0.03% | 118 |
|
|
2017
Q4 | $60K | Buy |
+738
| New | +$59.1K | 0.04% | 119 |
|
Other funds holding MDT
VCM
VPM
McIlrath & Eck's MDT Position: Q1 2026 in Review
McIlrath & Eck increased its Medtronic (MDT) stake by 113% in Q1 2026, buying an estimated $49.7K and bringing the position to 980 shares worth $84.9K. The position accounts for 0.01% of the portfolio, ranked #409.
McIlrath & Eck first reported a position in MDT in Q4 2017 and has held it in 34 quarters since. The position peaked at $141K in Q4 2020. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- McIlrath & Eck held 980 shares of Medtronic worth $84.9K as of Q1 2026.
- McIlrath & Eck bought 519 Medtronic shares in Q1 2026, an estimated $49.7K.
- Medtronic made up 0.01% of McIlrath & Eck's portfolio in Q1 2026, its #409 holding.
- McIlrath & Eck first reported a position in Medtronic in Q4 2017 and has held it in 34 quarters since.
- McIlrath & Eck's Medtronic position peaked at $141K in Q4 2020.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.